Nicholas Company, Inc. Abb Vie Inc. Transaction History

Nicholas Company, Inc.

$5.86 Billion
Q3 2024

A detailed history of Nicholas Company, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Nicholas Company, Inc. holds 40,780 shares of ABBV stock, worth $7.22 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares

40,780

Previous 46,865 12.98%

Holding current value

$7.22 Million

Previous $8.04 Million 0.19%

% of portfolio

0.14%

Previous 0.14%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$163.84 - $199.33 $996,966 - $1.21 Million	-6,085 Reduced 12.98%	40,780 $8.05 Million
Q2 2024 Jul 24, 2024	SELL	$154.79 - $180.76 $1.68 Million - $1.96 Million	-10,830 Reduced 18.77%	46,865 $8.04 Million
Q3 2023 Feb 13, 2024	SELL	$133.59 - $154.65 $33,397 - $38,662	-250 Reduced 0.43%	57,695 $8.6 Million
Q3 2023 Nov 13, 2023	SELL	$133.59 - $154.65 $33,397 - $38,662	-250 Reduced 0.43%	57,695 $8.6 Million
Q1 2023 Feb 13, 2024	BUY	$144.61 - $166.54 $1.17 Million - $1.34 Million	8,065 Added 16.17%	57,945 $9.23 Million
Q1 2023 May 11, 2023	BUY	$144.61 - $166.54 $1.17 Million - $1.34 Million	8,065 Added 16.17%	57,945 $9.23 Million
Q3 2022 Feb 13, 2024	BUY	$134.21 - $153.93 $4,026 - $4,617	30 Added 0.06%	49,880 $6.69 Million
Q3 2022 Nov 14, 2022	BUY	$134.21 - $153.93 $4,026 - $4,617	30 Added 0.06%	49,880 $6.69 Million
Q2 2022 Feb 13, 2024	SELL	$137.62 - $174.96 $487,174 - $619,358	-3,540 Reduced 6.63%	49,850 $7.64 Million
Q2 2022 Jul 26, 2022	SELL	$137.62 - $174.96 $487,174 - $619,358	-3,540 Reduced 6.63%	49,850 $7.64 Million
Q1 2022 Feb 13, 2024	SELL	$131.98 - $163.75 $568,173 - $704,943	-4,305 Reduced 7.46%	53,390 $8.66 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $380,302 - $481,192	3,540 Added 7.1%	53,390 $7.23 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $537,852 - $610,542	5,055 Added 11.28%	49,850 $5.38 Million
Q2 2021 Aug 12, 2021	BUY	$105.21 - $117.21 $315,630 - $351,630	3,000 Added 7.18%	44,795 $5.05 Million
Q1 2021 May 14, 2021	BUY	$102.3 - $112.62 $4.28 Million - $4.71 Million	41,795 New	41,795 $4.52 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nicholas Company, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nicholas Company, Inc. with notifications on news.

Account

Nicholas Company, Inc. Abb Vie Inc. Transaction History